精神障碍类疾病神经调控新进展

张新, 吴精川, 陈亮

PDF(956 KB)
PDF(956 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (05) : 643-648. DOI: 10.13406/j.cnki.cyxb.003484
精神疾病及功能性神经疾病的治疗

精神障碍类疾病神经调控新进展

作者信息 +

New advances in neuromodulation for mental disorders

Author information +
History +

摘要

精神障碍类疾病是一类涉及认知、情感、思维和行为的疾病,其临床表现各异,致病机制复杂,病因尚未被彻底阐明,目前仍无有效的针对性治疗方案,是当前医学领域的难点之一。近年研究结果表明,以电、磁、光、声为基础开发的新型神经调控手段可以有效的治疗或缓解各类药物难治性精神类疾病的临床症状。因此本文将聚焦于总结和回顾各类新型神经调控手段的研发与应用进展,为精神障碍类疾病治疗方案的更新提供新思路。

Abstract

Mental disorders encompass a spectrum of conditions involving disturbances in cognition,emotion,thinking,and behavior, with diverse clinical manifestations and complex pathogenic mechanisms. The etiology of these disorders remains unclear,and there are still no effective targeted treatment regimens,posing a significant challenge in the field of medicine. Recent research findings have shown that novel neuroregulation techniques based on electricity,magnetism,light,and sound can effectively treat or alleviate the clinical symptoms of various medically intractable mental disorders. Therefore,this article summarizes and reviews the advances in the development and application of various novel neuroregulation techniques,so as to provide new insights for updating the treatment regimens for mental disorders.

关键词

精神障碍 / 神经调控 / 脑深部电刺激 / 迷走神经刺激 / 经颅磁刺激

Key words

mental disorders / neuromodulation / deep brain stimulation / vagus nerve stimulation / transcranial magnetic stimulation

中图分类号

R749

引用本文

导出引用
张新 , 吴精川 , 陈亮. 精神障碍类疾病神经调控新进展. 重庆医科大学学报. 2024, 49(05): 643-648 https://doi.org/10.13406/j.cnki.cyxb.003484
Zhang Xin, Wu Jingchuan, Chen Liang. New advances in neuromodulation for mental disorders[J]. Journal of Chongqing Medical University. 2024, 49(05): 643-648 https://doi.org/10.13406/j.cnki.cyxb.003484

参考文献

1
McGinty EE Alegria M Beidas RS,et al. The lancet psychiatry commission:transforming mental health implementation research[J]. Lancet Psychiatry202411(5):368-396.
2
Favril L Rich JD Hard J,et al. Mental and physical health morbidity among people in prisons:an umbrella review[J]. Lancet Public Health20249(4):e250-e260.
3
Del Palacio-Gonzalez A Thylstrup B Rømer Thomsen K. Psychological factors predicting patients' risk of relapse after enrollment in drug use treatment:a systematic review[J]. J Subst Use Addict Treat2024161:209354.
4
Kim HK Voineskos AN Neufeld NH,et al. Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features[J/OL]. Mol Psychiatry2024[epub ahead of print]. doi: 10.1038/s41380-024-02523-7.
5
Gerchen MF Glock C Weiss F,et al. The truth is in there:belief processes in the human brain[J]. Psychophysiology2024:e14561.
6
Leehr EJ Seeger FR Böhnlein J,et al. Association between resting-state connectivity patterns in the defensive system network and treatment response in spider phobia-a replication approach[J]. Transl Psychiatry202414(1):137.
7
Stępnicki P Targowska-Duda KM Martínez AL,et al. Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design,synthesis,structural studies and pharmacological profiling[J]. Eur J Med Chem2023252:115285.
8
McCall A Forouhandehpour R Celebi S,et al. Evidence for locus coeruleus-norepinephrine system abnormality in military posttraumatic stress disorder revealed by neuromelanin-sensitive magnetic resonance imaging[J/OL]. Biol Psychiatry2024[epub ahead of print]. doi: 10.1016/j.biopsych.2024.01.013 .
9
Pirahanchi Y Jessu R Aeddula NR. Physiology,sodium potassium pump[M]. Treasure Island(FL):StatPearls Publishing,2023.
10
Zhang CL Chen ZJ Feng H,et al. C1q/tumor necrosis factor-related protein-3 enhances the contractility of cardiomyocyte by increasing calcium sensitivity[J]. Cell Calcium201766:90-97.
11
Lee J Han JH. Bimodal transformer with regional EEG data for accurate gameplay regularity classification[J]. Brain Sci202414(3):282.
12
Lin P Zhu G Xu XY,et al. Brain network analysis of working memory in schizophrenia based on multi graph attention network[J]. Brain Res20241831:148816.
13
Rockhill AP Mantovani A Stedelin B,et al. Stereo-EEG recordings extend known distributions of canonical movement-related oscillations[J/OL]. J Neural Eng2023[epub ahead of print]. doi: 10.1088/1741-2552/acae0a.
14
Greene P Li A González-Martínez J,et al. Classification of stereo-EEG contacts in white matter vs. gray matter using recorded activity[J]. Front Neurol202011:605696.
15
Heath RG, Pool JL. Treatment of psychoses with bilateral ablation of a focal area of the frontal cortex[J]. Psychosom Med194810(5): 254-256.
16
George MS Wassermann EM Williams WA,et al. Daily repetitive transcranial magnetic stimulation(rTMS) improves mood in depression[J]. Neuroreport19956(14):1853-1856.
17
Rush AJ George MS Sackeim HA,et al. Vagus nerve stimulation(VNS) for treatment-resistant depressions:a multicenter study[J]. Biol Psychiatry200047(4):276-286.
18
Strom NI Burton CL Iyegbe C,et al. Genome-Wide Association Study of Obsessive-Compulsive Symptoms including 33,943 individuals from the general population[J/OL]. Mol Psychiatry2024[epub ahead of print]. doi: 10.1038/s41380-024-02489-6.
19
Conti D Girone N Boscacci M,et al. The use of antipsychotics in obsessive compulsive disorder[J]. Hum Psychopharmacol202439(3):e2893.
20
Salinas M Yazdani U Oblack A,et al. Know DBS:patient perceptions and knowledge of deep brain stimulation in Parkinson's disease[J/OL]. Ther Adv Neurol Disord2024[epub ahead of print].doi: 10.1177/17562864241233038 .
21
Kahn L Sutton B Winston HR,et al. Deep brain stimulation for obsessive-compulsive disorder:real world experience post-FDA-humanitarian use device approval[J]. Front Psychiatry202112:568932.
22
Xu TT Gao Y Li B,et al. The efficacy and safety of deep brain stimulation of combined anterior limb of internal capsule and nucleus accumbens(ALIC/NAcc-DBS) for treatment-refractory obsessive-compulsive disorder:protocol of a multicenter,randomized,and double-blinded study[J]. Brain Sci202212(7):933.
23
Philipson J Naesstrom M Johansson JD,et al. Deep brain stimulation in the ALIC-BNST region targeting the bed nucleus of stria terminalis in patients with obsessive-compulsive disorder:effects on cognition after 12 months[J]. Acta Neurochir2023165(5):1201-1214.
24
Senova S Clair AH Palfi S,et al. Deep brain stimulation for refractory obsessive-compulsive disorder:towards an individualized approach[J]. Front Psychiatry201910:905.
25
Basich-Pease G Slepneva N Frank AC,et al. Tractography-based DBS lead repositioning improves outcome in refractory OCD and depression[J]. Front Hum Neurosci202317:1339340.
26
Zhang B He P Lawrence JEG,et al. A human embryonic limb cell atlas resolved in space and time[J/OL]. Nature2023[epub ahead of print]. doi: 10.1038/s41586-023-06806-x.
27
Öndemark M Nordström L Lindqvist PG. Dose-dependent increase in risk of bleeding and bleeding complications in relation to SSRI use at delivery[J]. Eur J Obstet Gynecol Reprod Biol2024296:265-269.
28
Bates N Bello JK Osazuwa-Peters N,et al. Depression and long-term prescription opioid use and opioid use disorder:implications for pain management in cancer[J]. Curr Treat Options Oncol202223(3):348-358.
29
Hovorka M Ewing D Middlemas DS. Chronic SSRI treatment,but not norepinephrine reuptake inhibitor treatment,increases neurogenesis in juvenile rats[J]. Int J Mol Sci202223(13):6919.
30
Van den Eynde V Abdelmoemin WR Abraham MM,et al. The prescriber's guide to classic MAO inhibitors(phenelzine,tranylcypromine,isocarboxazid) for treatment-resistant depression[J]. CNS Spectr2022:1-14.
31
Parker G. A revisionist model for treatment-resistant and difficult-to-treat depression[J/OL]. Aust N Z J Psychiatry2024[epub ahead of print]. doi: 10.1177/00048674241240600.
32
Austelle CW O'Leary GH Thompson S,et al. A comprehensive review of vagus nerve stimulation for depression[J]. Neuromodulation202225(3):309-315.
33
Carpenter LL Moreno FA Kling MA,et al. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites,norepinephrine,and gamma-aminobutyric acid concentrations in depressed patients[J]. Biol Psychiatry200456(6):418-426.
34
Hong J Xie HM Chen YH,et al. Effects of STN-DBS on cognition and mood in young-onset Parkinson's disease:a two-year follow-up[J]. Front Aging Neurosci202315:1177889.
35
Johnson KA Okun MS Scangos KW,et al. Deep brain stimulation for refractory major depressive disorder:a comprehensive review[J/OL]. Mol Psychiatry2024[epub ahead of print]. doi: 10.1038/s41380-023-02394-4.
36
Shepherd H Heartshorne R Osman-Farah J,et al. Dual target deep brain stimulation for complex essential and dystonic tremor - A 5-year follow up[J]. J Neurol Sci2024457:122887.
37
Jiménez F Nicolini H Lozano AM,et al. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders[J]. World Neurosurg201380(3/4):S30.e17-S30.e25.
38
Tong Y Cho S Coenen VA,et al. Input-output relation of midbrain connectomics in a rodent model of depression[J]. J Affect Disord2024345:443-454.
39
Naesström M Hariz M Strömsten L,et al. Deep brain stimulation in the bed nucleus of stria Terminalis in obsessive-compulsive disorder-1-year follow-up[J]. World Neurosurg2021149:e794-e802.
40
Scherer M Harmsen IE Samuel N,et al. Oscillatory network markers of subcallosal cingulate deep brain stimulation for depression[J]. Brain Stimul202316(6):1764-1775.
41
Elias GJB Germann J Loh A,et al. Habenular involvement in response to subcallosal cingulate deep brain stimulation for depression[J]. Front Psychiatry202213:810777.
42
Hitti FL Cristancho MA Yang AI,et al. Deep brain stimulation of the ventral capsule/ventral Striatum for treatment-resistant depression:a decade of clinical follow-up[J]. J Clin Psychiatry202182(6):21m13973.
43
Kubu CS Brelje T Butters MA,et al. Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression[J]. J Neurol Neurosurg Psychiatry201788(3):262-265.
44
Singh LK Giri AK Chhalotre V,et al. Prevalence of psychiatric disorders in chhattisgarh:findings from national mental health survey[J]. Indian J Psychol Med202345(6):573-579.
45
Fiorillo A Sampogna G Albert U,et al. The role of lurasidone in managing depressive symptoms in people with schizophrenia:a review[J]. Brain Sci202414(3):225.
46
Sangüesa E Fernández-Egea E Concha J,et al. Impact of pharmacogenetic testing on clozapine treatment efficacy in patients with treatment-resistant schizophrenia[J]. Biomedicines202412(3):597.
47
Mehta DD Siddiqui S Ward HB,et al. Functional and structural effects of repetitive transcranial magnetic stimulation(rTMS) for the treatment of auditory verbal hallucinations in schizophrenia:a systematic review[J]. Schizophr Res2024267:86-98.
48
Xie YJ Li CX Guan MZ,et al. Low-frequency rTMS induces modifications in cortical structural connectivity - functional connectivity coupling in schizophrenia patients with auditory verbal hallucinations[J]. Hum Brain Mapp202445(3):e26614.
49
Walther S Alexaki D Weiss F,et al. Psychomotor slowing in psychosis and inhibitory repetitive transcranial magnetic stimulation:a randomized clinical trial[J]. JAMA Psychiatry2024:e240026.
50
Bioque M Rumià J Roldán P,et al. Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder:a case series[J/OL]. Rev Psiquiatr Salud Ment2023[epub ahead of print]. doi: 10.1016/j.rpsm.2023.05.001.
51
Yan H Elkaim LM Venetucci Gouveia F,et al. Deep brain stimulation for extreme behaviors associated with autism spectrum disorder converges on a common pathway:a systematic review and connectomic analysis[J]. J Neurosurg2022:1-10.
52
Blum K Ashford JW Kateb B,et al. Dopaminergic dysfunction:role for genetic & epigenetic testing in the new psychiatry[J]. J Neurol Sci2023453:120809.
53
Jerlhag E Egecioglu E Dickson SL,et al. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system[J]. Addict Biol201116(1):82-91.
54
Voges J Müller U Bogerts B,et al. Deep brain stimulation surgery for alcohol addiction[J]. World Neurosurg201380(3/4):e21-31.
55
Harmelech T Hanlon CA Tendler A. Transcranial magnetic stimulation as a tool to promote smoking cessation and decrease drug and alcohol use[J]. Brain Sci202313(7):1072.
56
Petit B Soudry-Faure A Jeanjean L,et al. Efficacy of repetitive transcranial magnetic stimulation(rTMS) for reducing consumption in patients with alcohol use disorders(ALCOSTIM):study protocol for a randomized controlled trial[J]. Trials202223(1):33.
57
Siddiqi S Akther A Blair DL,et al. Eating disorders among international migrants:a systematic review and meta-analysis[J/OL]. Soc Psychiatry Psychiatr Epidemiol2024[epub ahead of print]. doi: 10.1007/s00127-024-02666-6.
58
Haddad-Tóvolli R Ramírez S Muñoz-Moreno E,et al. Food craving-like episodes during pregnancy are mediated by accumbal dopaminergic circuits[J]. Nat Metab20224(4):424-434.
59
Wu K Lo YT Cavaleri J,et al. Neuromodulation of eating disorders:a review of underlying neural network activity and neuromodulatory treatments[J]. Brain Sci202414(3):200.
60
Liu W Zhan SK Li DY,et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory anorexia nervosa:a long-term follow-up study[J]. Brain Stimul202013(3):643-649.

基金

国家自然科学基金面上资助项目(82272116)

评论

PDF(956 KB)

Accesses

Citation

Detail

段落导航
相关文章

/